These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. New insights into the global burden of noroviruses and opportunities for prevention. Hall AJ; Glass RI; Parashar UD Expert Rev Vaccines; 2016 Aug; 15(8):949-51. PubMed ID: 27142965 [No Abstract] [Full Text] [Related]
9. Interferon responses to norovirus infections: current and future perspectives. Jahun AS; Goodfellow IG J Gen Virol; 2021 Oct; 102(10):. PubMed ID: 34698626 [TBL] [Abstract][Full Text] [Related]
10. Mendelian resistance to human norovirus infections. Le Pendu J; Ruvoën-Clouet N; Kindberg E; Svensson L Semin Immunol; 2006 Dec; 18(6):375-86. PubMed ID: 16973373 [TBL] [Abstract][Full Text] [Related]
11. Noroviruses: epidemiology, immunity and prospects for prevention. Pringle K; Lopman B; Vega E; Vinje J; Parashar UD; Hall AJ Future Microbiol; 2015; 10(1):53-67. PubMed ID: 25598337 [TBL] [Abstract][Full Text] [Related]
12. Human norovirus transmission and evolution in a changing world. de Graaf M; van Beek J; Koopmans MP Nat Rev Microbiol; 2016 Jul; 14(7):421-33. PubMed ID: 27211790 [TBL] [Abstract][Full Text] [Related]
13. Immune mechanisms responsible for vaccination against and clearance of mucosal and lymphatic norovirus infection. Chachu KA; LoBue AD; Strong DW; Baric RS; Virgin HW PLoS Pathog; 2008 Dec; 4(12):e1000236. PubMed ID: 19079577 [TBL] [Abstract][Full Text] [Related]
14. Norovirus Infection: Replication, Manipulation of Host, and Interaction with the Host Immune Response. Sarvestani ST; Cotton B; Fritzlar S; O'Donnell TB; Mackenzie JM J Interferon Cytokine Res; 2016 Apr; 36(4):215-25. PubMed ID: 27046239 [TBL] [Abstract][Full Text] [Related]
15. Norovirus P particle: a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus. Tan M; Jiang X Nanomedicine (Lond); 2012 Jun; 7(6):889-97. PubMed ID: 22734641 [TBL] [Abstract][Full Text] [Related]
16. Norovirus vaccines under development. Lucero Y; Vidal R; O'Ryan G M Vaccine; 2018 Aug; 36(36):5435-5441. PubMed ID: 28668568 [TBL] [Abstract][Full Text] [Related]
17. Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity. Nice TJ; Baldridge MT; McCune BT; Norman JM; Lazear HM; Artyomov M; Diamond MS; Virgin HW Science; 2015 Jan; 347(6219):269-73. PubMed ID: 25431489 [TBL] [Abstract][Full Text] [Related]
19. Differentiation and Protective Capacity of Virus-Specific CD8 Tomov VT; Palko O; Lau CW; Pattekar A; Sun Y; Tacheva R; Bengsch B; Manne S; Cosma GL; Eisenlohr LC; Nice TJ; Virgin HW; Wherry EJ Immunity; 2017 Oct; 47(4):723-738.e5. PubMed ID: 29031786 [TBL] [Abstract][Full Text] [Related]
20. Understanding the relationship between norovirus diversity and immunity. Ford-Siltz LA; Tohma K; Parra GI Gut Microbes; 2021; 13(1):1-13. PubMed ID: 33783322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]